These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 11230997

  • 1. Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on doxorubicin-induced cardiotoxicity in the rat.
    Sacco G, Bigioni M, Evangelista S, Goso C, Manzini S, Maggi CA.
    Eur J Pharmacol; 2001 Feb 23; 414(1):71-8. PubMed ID: 11230997
    [Abstract] [Full Text] [Related]

  • 2. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.
    Sacco G, Mario B, Lopez G, Evangelista S, Manzini S, Maggi CA.
    Vascul Pharmacol; 2009 Feb 23; 50(5-6):166-70. PubMed ID: 19344651
    [Abstract] [Full Text] [Related]

  • 3. Cardioprotective effects of zofenopril, enalapril and valsartan against ischaemia/reperfusion injury as well as doxorubicin cardiotoxicity.
    Bozcali E, Dedeoglu DB, Karpuz V, Suzer O, Karpuz H.
    Acta Cardiol; 2012 Feb 23; 67(1):87-96. PubMed ID: 22455094
    [Abstract] [Full Text] [Related]

  • 4. Converting enzyme inhibition after experimental myocardial infarction in rats: comparative study between spirapril and zofenopril.
    van Wijngaarden J, Pinto YM, van Gilst WH, de Graeff PA, de Langen CD, Wesseling H.
    Cardiovasc Res; 1991 Nov 23; 25(11):936-42. PubMed ID: 1813122
    [Abstract] [Full Text] [Related]

  • 5. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
    Westendorp B, Schoemaker RG, van Gilst WH, van Veldhuisen DJ, Buikema H.
    Eur J Pharmacol; 2005 Dec 19; 527(1-3):141-9. PubMed ID: 16310764
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effects of oral pretreatment with zofenopril, an angiotensin-converting enzyme inhibitor, on early reperfusion and subsequent electrophysiologic stability in the pig.
    Tio RA, de Langen CD, de Graeff PA, van Gilst WH, Bel KJ, Wolters KG, Mook PH, van Wijngaarden J, Wesseling H.
    Cardiovasc Drugs Ther; 1990 Jun 19; 4(3):695-703. PubMed ID: 2076380
    [Abstract] [Full Text] [Related]

  • 8. Antioxidant and cardioprotective properties of the sulphydryl angiotensin-converting enzyme inhibitor zofenopril.
    Evangelista S, Manzini S.
    J Int Med Res; 2005 Jun 19; 33(1):42-54. PubMed ID: 15651714
    [Abstract] [Full Text] [Related]

  • 9. Effects of zofenopril on myocardial ischemia in post-myocardial infarction patients with preserved left ventricular function: the Survival of Myocardial Infarction Long-term Evaluation (SMILE)-ISCHEMIA study.
    Borghi C, Ambrosioni E, Survival of Myocardial Infarction Long-term Evaluation Study Group.
    Am Heart J; 2007 Mar 19; 153(3):445.e7-14. PubMed ID: 17307427
    [Abstract] [Full Text] [Related]

  • 10. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J, Ortiz MC, O'Valle F, Alcaraz A, Navarro EG, Vargas F, Evangelista S, Atucha NM.
    Clin Sci (Lond); 2006 Feb 19; 110(2):227-33. PubMed ID: 16197366
    [Abstract] [Full Text] [Related]

  • 11. Comparison of doxorubicin- and MEN 10755-induced long-term progressive cardiotoxicity in the rat.
    Cirillo R, Sacco G, Venturella S, Brightwell J, Giachetti A, Manzini S.
    J Cardiovasc Pharmacol; 2000 Jan 19; 35(1):100-8. PubMed ID: 10630739
    [Abstract] [Full Text] [Related]

  • 12. Protection of the ischemic myocardium by the converting-enzyme inhibitor zofenopril: insight into its mechanism of action.
    Ferrari R, Cargnoni A, Curello S, Ceconi C, Boraso A, Visioli O.
    J Cardiovasc Pharmacol; 1992 Jan 19; 20(5):694-704. PubMed ID: 1280730
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dietary sodium restriction specifically potentiates left ventricular ACE inhibition by zofenopril, and is associated with attenuated hypertrophic response in rats with myocardial infarction.
    Westendorp B, Schoemaker RG, Buikema H, de Zeeuw D, van Veldhuisen DJ, van Gilst WH.
    J Renin Angiotensin Aldosterone Syst; 2004 Mar 19; 5(1):27-32. PubMed ID: 15136971
    [Abstract] [Full Text] [Related]

  • 15. Zofenopril exerts a cardiovascular protective effect on rats infused with angiotensin II beyond angiotensin-converting enzyme inhibition.
    Gómez-Roso M, Montero MJ, Carrón R, Sevilla MA.
    J Pharm Pharmacol; 2016 Nov 19; 68(11):1422-1429. PubMed ID: 27670145
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of zofenopril on cardiac sarcoplasmic reticulum calcium handling.
    Frascarelli S, Carnicelli V, Ghelardoni S, Chiellini G, Ronca F, Zucchi R.
    J Cardiovasc Pharmacol; 2009 Nov 19; 54(5):456-63. PubMed ID: 19738489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.